MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to maravai...
-$3,733K
(87.53%↑ Y/Y)
Net loss
attributable to...
-$2,644K
(88.46%↑ Y/Y)
Nucleic Acid Production
Segment
$27,953K
(27.21%↑ Y/Y)
Biologics Safety Testing
Segment
$7,736K
(6.05%↑ Y/Y)
Nucleic Acid Production
Segment
$17,531K
(575.83%↑ Y/Y)
Biologics Safety Testing
Segment
$4,416K
(3.08%↑ Y/Y)
Biologics Safety Testing
Segment
$5,963K
(-6.97%↓ Y/Y)
Nucleic Acid Production
Segment
$1,909K
(-53.97%↓ Y/Y)
Biologics Safety Testing
Segment
$246K
(121.62%↑ Y/Y)
Nucleic Acid Production
Segment
$83K
(137.14%↑ Y/Y)
Net loss
-$6,377K
(87.93%↑ Y/Y)
Income tax (benefit)
expense
-$151K
(-193.21%↓ Y/Y)
North America
$35,689K
(21.93%↑ Y/Y)
EMEA
$21,947K
(219.09%↑ Y/Y)
Asia Pacific
$7,872K
(-25.43%↓ Y/Y)
Latin And Central
America
$329K
(125.34%↑ Y/Y)
Loss before income
taxes
-$6,528K
(87.61%↑ Y/Y)
Interest income
$1,873K
(-41.92%↓ Y/Y)
Revenue
$65,837K
(40.53%↑ Y/Y)
Interest expense
$5,749K
(-15.18%↓ Y/Y)
Loss from operations
-$2,158K
(95.61%↑ Y/Y)
Gross profit
$33,701K
Other (expense)
income
-$494K
(-2158.33%↓ Y/Y)
Cost of revenue
$32,136K
(-17.86%↓ Y/Y)
Total operating
expenses
$35,859K
(-62.65%↓ Y/Y)
Selling, general and
administrative
$29,092K
(-26.47%↓ Y/Y)
Research and development
$3,889K
(-20.44%↓ Y/Y)
Restructuring
$2,878K
Back
Back
Income Statement
source: myfinsight.com
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)